Intravenous Chemotherapy Versus Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Conditions
Brief summary
This study aims to compare intravenous chemotherapy versus intraperitoneal chemotherapy in patients with recurrent ovarian cancer.
Interventions
DRUGChemotherapy
Intravenous chemotherapy versus intraperitoneal chemotherapy in recurrent ovarian cancer
Sponsors
Far Eastern Memorial Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
20 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* women who had recurrent ovarian cancer and was treated with either intravenous or intraperitoneal platinum based chemotherapy
Exclusion criteria
* women who did not complete the designated treatment course (exception to those who had to quit due to progressive disease or death of any cause)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| RFS | the time interval from the date of surgery or the start of chemotherapy to clinically defined recurrence, disease progression, death from any cause or last follow-up | Recurrence free survival |
| OS | the time interval from the date of surgery or the start of chemotherapy to the date of death from any cause or last follow-up | Overall Survival |
Countries
Taiwan
Outcome results
None listed